JP2024520751A5 - - Google Patents
Info
- Publication number
- JP2024520751A5 JP2024520751A5 JP2023575364A JP2023575364A JP2024520751A5 JP 2024520751 A5 JP2024520751 A5 JP 2024520751A5 JP 2023575364 A JP2023575364 A JP 2023575364A JP 2023575364 A JP2023575364 A JP 2023575364A JP 2024520751 A5 JP2024520751 A5 JP 2024520751A5
- Authority
- JP
- Japan
- Prior art keywords
- disorder
- salt
- acid
- disease
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163197848P | 2021-06-07 | 2021-06-07 | |
| US63/197,848 | 2021-06-07 | ||
| PCT/US2022/072802 WO2022261633A1 (en) | 2021-06-07 | 2022-06-07 | Novel salts and crystals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520751A JP2024520751A (ja) | 2024-05-24 |
| JP2024520751A5 true JP2024520751A5 (cg-RX-API-DMAC7.html) | 2025-06-16 |
Family
ID=84425422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575364A Pending JP2024520751A (ja) | 2021-06-07 | 2022-06-07 | 新規塩および結晶 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240279228A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4352057A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024520751A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240018528A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117425652A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022289909A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3217549A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL308750A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014398A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022261633A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2743513C2 (ru) | 2016-01-26 | 2021-02-19 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
| WO2019067591A1 (en) | 2017-09-26 | 2019-04-04 | Intra-Cellular Therapies, Inc. | NEW SALTS AND CRYSTALS |
| IL315005B2 (en) | 2018-12-17 | 2026-04-01 | Intra Cellular Therapies Inc | Substituted heterocycle fused gamma-carbolines synthesis |
| ES3047409T3 (en) | 2018-12-17 | 2025-12-03 | Intra Cellular Therapies Inc | Substituted heterocycle fused gamma-carbolines synthesis |
| US12331052B2 (en) | 2018-12-21 | 2025-06-17 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2530090T3 (es) * | 2008-03-12 | 2015-02-26 | Intra-Cellular Therapies, Inc. | Sólido de gamma-carbolinas fusionadas con heterociclo sustituido |
| RU2743513C2 (ru) * | 2016-01-26 | 2021-02-19 | Интра-Селлулар Терапиз, Инк. | Органические соединения |
| WO2017172811A1 (en) * | 2016-03-28 | 2017-10-05 | Intra-Cellular Therapies, Inc. | Novel co-crystals |
| EP3801527B1 (en) * | 2018-06-08 | 2025-02-19 | Intra-Cellular Therapies, Inc. | Fused gamma-carbolines for acute treatment of anxiety or depression |
| IL315005B2 (en) * | 2018-12-17 | 2026-04-01 | Intra Cellular Therapies Inc | Substituted heterocycle fused gamma-carbolines synthesis |
| JP7377871B2 (ja) * | 2018-12-21 | 2023-11-10 | イントラ-セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
-
2022
- 2022-06-07 IL IL308750A patent/IL308750A/en unknown
- 2022-06-07 MX MX2023014398A patent/MX2023014398A/es unknown
- 2022-06-07 KR KR1020237045333A patent/KR20240018528A/ko active Pending
- 2022-06-07 WO PCT/US2022/072802 patent/WO2022261633A1/en not_active Ceased
- 2022-06-07 US US18/567,743 patent/US20240279228A1/en active Pending
- 2022-06-07 CA CA3217549A patent/CA3217549A1/en active Pending
- 2022-06-07 EP EP22821240.3A patent/EP4352057A4/en active Pending
- 2022-06-07 JP JP2023575364A patent/JP2024520751A/ja active Pending
- 2022-06-07 CN CN202280040536.9A patent/CN117425652A/zh active Pending
- 2022-06-07 AU AU2022289909A patent/AU2022289909A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4151277B1 (en) | Substituted piperidine compound and application thereof | |
| US20230357243A1 (en) | Lsd derivatives, synthesis & method for treatment of diseases and disorders | |
| JP2014062108A (ja) | モノアミン再取り込み阻害薬としてのフェニル置換シクロアルキルアミン | |
| NZ244616A (en) | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, preparation and pharmaceutical compositions thereof | |
| JP2016510768A (ja) | 抗不安化合物の塩、共結晶及び多形 | |
| WO2023130117A1 (en) | Deuterated organic compounds and uses thereof | |
| WO2025010259A2 (en) | Deuterated organic compounds and uses thereof | |
| CN103781771B (zh) | 苯并噻唑酮化合物 | |
| CN104557568B (zh) | 烟碱受体非竞争性拮抗剂 | |
| CN102340992B (zh) | 吡咯烷三重再摄取抑制剂 | |
| AU2013221406B2 (en) | Peripherally restricted diphenyl purine derivatives | |
| KR20240134870A (ko) | 치환된 피페리딘 화합물의 결정, 치환된 피페리딘 화합물의 염, 및 이의 결정 | |
| CN113784755B (zh) | 异色满基化合物的盐及其结晶形式、制备方法、治疗用途和药物组合物 | |
| US11396511B2 (en) | Substituted 9,13b-dihydro-1H-dibenzo[c,f]imidazo[1,5-a]azepin-3-ylbenzamides as anti-inflammatory and analgesic agents | |
| JPWO2007126020A1 (ja) | Nmda受容体チャネルブロック作用を示す化合物及びそれを用いた薬剤。 | |
| TW201136588A (en) | Tropinone benzylamines as beta-tryptase inhibitors | |
| JP7591592B2 (ja) | 置換ピペリジン化合物を含有する医薬 | |
| CN104736525B (zh) | 作为β-2肾上腺受体激动剂的苯并噻唑酮化合物的盐 | |
| CN118284607A (zh) | 用于治疗疾病和障碍的lsd衍生物、合成和方法 | |
| TW201249841A (en) | Novel salt forms of 3-cyclopropylcarbonyl-3,6-diazabicyclo[3.1.1]heptane | |
| KR20140098115A (ko) | 니코틴 수용체 비-경쟁적 조절제 | |
| HK1144931A (en) | Amino acid derivatives | |
| HK1163451B (en) | Pyrrolidine triple reuptake inhibitors | |
| JP2011522016A (ja) | 4−ブロモフェニル1,4−ジアザビシクロ[3.2.2]ノナン−4−カルボキシラートのフマル酸塩、この結晶形態、調製、および治療的使用 |